Albert Lung

Within the United States, Albert represents companies spanning an array of industries, particularly emerging technology and life sciences companies in Silicon Valley, as they accelerate their growth through venture financing transactions, private placements and public offerings, mergers and acquisitions (M&A), and other business transactions. He has experience in guiding public companies, underwriters and private equity firms through initial public offerings (IPOs), follow-on and secondary public offerings, private investment in public equity (PIPEs), At-the-Market Offering , Rule 144A offerings, tender offers and convertible debt financing.

Albert is a leading practitioner of Regulation A+ IPOs and has represented both issuers and underwriters in some of the first Regulation A+ IPOs since the adoption of the new rules by the SEC. Albert also advises private companies in venture capital financing and other complex corporate finance and M&A transactions, including Regulation CF offering and Rule 506(c) offering.

Companies in the Asia-Pacific region that are looking for financing from US-based corporations seek Albert’s counsel on navigating complex securities law issues associated with cross-border financing and acquisition transactions. His understanding of US securities law and disclosure requirements allows him to find the most efficient ways for clients to raise funds from inside the United States.

Albert writes and speaks frequently on topics relating to US securities laws, including the JOBS Act, Dodd Frank Act, and more recently he plays a leading role in developing the Regulation A+ legal practice.